Vanda Pharmaceuticals
VNDA
#7861
Rank
โ‚น28.61 B
Marketcap
โ‚น484.22
Share price
3.65%
Change (1 day)
19.62%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น12.14 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's total liabilities are โ‚น12.14 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vanda Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น10.09 B17.11%
2023-12-31โ‚น8.61 B-2.7%
2022-12-31โ‚น8.85 B33.93%
2021-12-31โ‚น6.61 B12.78%
2020-12-31โ‚น5.86 B12.96%
2019-12-31โ‚น5.19 B30.93%
2018-12-31โ‚น3.96 B-16.12%
2017-12-31โ‚น4.72 B-11.99%
2016-12-31โ‚น5.37 B1.01%
2015-12-31โ‚น5.31 B670.72%
2014-12-31โ‚น0.68 B-88.74%
2013-12-31โ‚น6.13 B-10.82%
2012-12-31โ‚น6.87 B-12.88%
2011-12-31โ‚น7.88 B0.4%
2010-12-31โ‚น7.85 B-16.44%
2009-12-31โ‚น9.40 B4899.58%
2008-12-31โ‚น0.18 B-63.5%
2007-12-31โ‚น0.51 B22.44%
2006-12-31โ‚น0.42 B83.84%
2005-12-31โ‚น0.22 B192.3%
2004-12-31โ‚น78.32 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
โ‚น5.618 T 46,175.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
โ‚น8.182 T 67,299.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น10.199 T 83,915.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น7.033 T 57,831.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น10.388 T 85,466.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
โ‚น23.62 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น6.974 T 57,350.37%๐Ÿ‡บ๐Ÿ‡ธ USA